atoltivimab (Inmazeb) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Breakthrough Therapy FDA

Active Ingredient History

  • Now

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Combination drugs

( atoltivimab (Inmazeb), maftivimab (Inmazeb), odesivimab (Inmazeb) - other name: atoltivimab, maftivimab, and odesivimab-ebgn )


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue